Diabetes Prevention Program

Prevention of Type 2 Diabetes Lifestyle Modification Program



In April 2007, the Council of Australian Governments (COAG) agreed to a cost shared package of over $200 million to address the significant growth in type 2 diabetes.  The Australian Government announced that its major contribution to this measure will focus on people in the 40-49 year old age group with the objective of reducing or delaying their progression to type 2 diabetes. From 1 July 2011 this program commenced its exit strategy year and will cease on 30 June 2012. All Lifestyle Modification Program groups will cease on or before 30 April 2012. Alternative referral options.

From 1 May 2010, the previous Medicare Benefits Schedule (MBS) Item 713 was abolished and general practitioners (GPs) will have:

  • evaluated eligible patients in the 40-49 year old age group at high risk of developing type 2 diabetes as determined by the Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK) with a score of 12 or above;
  • provided lifestyle modification advice for eligible patients and where appropriate; and
  • refered eligible patients to attend a subsidised lifestyle modification program (LMP) aimed at reducing the risk or delaying the progression to type 2 diabetes.

A medical practitioner may select MBS item 701 (brief), 703 (standard), 705 (long), or 707 (prolonged) to undertake a type 2 diabetes risk evaluation depending on the length of the consultation as determined by the complexity of the patient's presentation. The aim of the type 2 diabetes risk evaluation was to support medical practitioners to address the health needs of patients 40 to 49 years of age who are at high risk of developing type 2 diabetes. The type 2 diabetes risk evaluation was a review of the risk factors underlying the patient's "high risk" score as identified by the Australian Type 2 Diabetes Risk Assessment Tool. Prior to the exit strategy, it included initiating interventions, such as referral to lifestyle modification programs, to assist with the prevention of type 2 diabetes. The intention of a lifestyle modification program was to help people modify their risk factors to delay or prevent the onset of type 2 diabetes.

General Practice NSW liaises closely with the Australian General Practice Network (AGPN) and the Department of Health and Ageing (DoHA) to provide comprehensive support to the NSW Divisions Network.

Australian Type 2 Diabetes Risk Assessment Tool

The Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK) has been developed by the International Diabetes Institute (IDI) and is based on the Finnish "risk test" but has been adapted for the Australian clinical setting using AUSDIAB data.  It has been developed to provide a basis for both health professionals and health consumers to assess the risk of developing type 2 diabetes over a 5 year period.  It consists of a short list of questions that, when completed, provide a guide to a patient's current level of risk of developing type 2 diabetes. The item scores and risk rating calculations in the tool have been developed using demographic, lifestyle, anthropometric and biomedical data from the 2000 Australian Diabetes, Obesity and Lifestyle baseline survey and the AusDiab 2005 follow-up study.

The completion of the Australian Type 2 Diabetes Risk Assessment Tool and a high score result will be mandatory for the patient to access the LMP subsidised program.  It may be completed by either the patient or with the assistance of a health professional or practice staff and must meet a score of 12 or over.